PMID: 11343987May 10, 2001Paper

Early growth-response factor 1 and basic transcriptional element-binding protein 2 expression in cardiac allografts

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
Y WadaJ Amano

Abstract

Early growth-response factor 1 (Egr-1) and basic transcriptional element-binding protein 2 (BTEB2) are transcriptional factors that regulate multiple genes involved in phenotypic changes of smooth muscle cells (SMCs), one of the outstanding pathologic features of chronic cardiac allograft rejection. In this study, we used a heterotopic abdominal heart transplant model in monkeys to evaluate the roles of these molecules in graft coronary vasculopathy. We demonstrated that Egr-1 and BTEB2 are induced in vascular SMCs of rejected cardiac allografts well before morphologic changes, such as intimal thickening. These findings suggest that expression of Egr-1 and BTEB2 is one of the initial events in allograft angiopathy.

References

Feb 1, 1969·The Journal of Thoracic and Cardiovascular Surgery·K Ono, E S Lindsey
Jan 1, 1995·Progress in Nucleic Acid Research and Molecular Biology·A Gashler, V P Sukhatme
Mar 24, 1995·The Journal of Biological Chemistry·E J KilbourneS K Karathanasis
Jan 1, 1997·The Journal of Thoracic and Cardiovascular Surgery·J AmanoM Hiroe
Mar 18, 1999·The American Journal of Pathology·E S Silverman, T Collins
Oct 9, 1999·The American Journal of Pathology·E S SilvermanT Collins

❮ Previous
Next ❯

Citations

Jul 17, 2004·Transplantation·Michael V AutieriHoward J Eisen
May 19, 2009·Cellular and Molecular Life Sciences : CMLS·Jin-Tang Dong, Ceshi Chen
Dec 29, 2009·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Tatsuichiro SetoKen-ichi Ito
Sep 24, 2004·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Edward D Verrier
Feb 4, 2006·Circulation Research·Levon M Khachigian
Feb 14, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Raimo TuuminenKarl B Lemström

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery
Eleonora SimeoniGiuseppe Vassalli
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
Atsushi YamaguchiRobert C Robbins
© 2021 Meta ULC. All rights reserved